Clinical efficacy of second generation tyrosine kinase inhibitor and 5-azacytidine combination in chronic myelogenous leukaemia in myeloid blast crisis.
暂无分享，去创建一个
F. Pasquier | J. Bourhis | S. de Botton | P. Rousselot | C. Terré | J. Micol | V. Saada | N. Auger | D. Ghez | S. Rigaudeau | J. Ianotto | M. Spentchian | S. Castaigne | A. Bennaceur-Griscelli